Tag: U.S. Food and Drug Administration
Steel Therapeutics completes first steps for Fizurex FDA approval
North Liberty-based Steel Therapeutics, an early stage pharmarceutical company focused on increasing access to compounded drug therapies, announced Sept. 12 it has completed pre-investigational...
Report: Biosimiliars could save Iowa $142 million annually
A report from the Biosimilars Forum, in partnership with the Pacific Research Institute, revealed that Iowa could save $142 million annually for its patients,...
KemPharm ADHD treatment hits regulatory milestone
By CBJ News Staff
[email protected]
KemPharm, Inc. announced today the U.S. Food and Drug Administration had accepted the New Drug Application for its investigational attention deficit...